1-Allyloxy-4-bromo-2-methylbenzene | 309947-09-9

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯酚醚
• 英文名称: 1-Allyloxy-4-bromo-2-methylbenzene
• 英文别名: 1-Bromo-4-allyloxy-3-methylbenzene；4-bromo-2-methyl-1-prop-2-enoxybenzene
• CAS: 309947-09-9
• 化学式: C₁₀H₁₁BrO
• 分子量: 227.101
• InChiKey: DFMLMQUBXUWVIW-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.6
• 重原子数：
  12
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.2
• 拓扑面积：
  9.2
• 氢给体数：
  0
• 氢受体数：
  1

反应信息

• 作为反应物：
  描述：

  1-Allyloxy-4-bromo-2-methylbenzene 在 四氧化锇 、 N-甲基吗啉氧化物 作用下， 以 丙酮 为溶剂， 生成 3-(4-Bromo-2-methylphenyloxy)propane-1,2-diol
  参考文献：
  名称：

  具有非常规中间相形态的液晶嵌段分子的设计：具有侧链烷基链的棒状玻拉两亲物

  摘要：

  已经合成了由联苯刚性核、每个末端的极性 2,3-二羟基丙氧基和横向位置的额外长烷基链组成的新型双亲分子。这些三元嵌段分子的结构通过改变烷基链的长度和位置、在 2,3-二羟丙基基团之一和刚性核之间引入额外的间隔单元，以及通过取代其中之一而系统地改变。 2,3-二羟基丙氧基由单个羟基组成。通过偏光显微镜、差示扫描量热法和 X 射线衍射研究了这些结构变化对这些新材料液晶特性的影响。这些研究表明，通过侧链的伸长，

  DOI：

  10.1021/ja003124k
• 作为产物：
  描述：

  2-甲基-4-溴苯甲醚 在 三溴化硼 、 potassium carbonate 作用下， 以 二氯甲烷 、 乙腈 为溶剂， 生成 1-Allyloxy-4-bromo-2-methylbenzene
  参考文献：
  名称：

  具有非常规中间相形态的液晶嵌段分子的设计：具有侧链烷基链的棒状玻拉两亲物

  摘要：

  已经合成了由联苯刚性核、每个末端的极性 2,3-二羟基丙氧基和横向位置的额外长烷基链组成的新型双亲分子。这些三元嵌段分子的结构通过改变烷基链的长度和位置、在 2,3-二羟丙基基团之一和刚性核之间引入额外的间隔单元，以及通过取代其中之一而系统地改变。 2,3-二羟基丙氧基由单个羟基组成。通过偏光显微镜、差示扫描量热法和 X 射线衍射研究了这些结构变化对这些新材料液晶特性的影响。这些研究表明，通过侧链的伸长，

  DOI：

  10.1021/ja003124k

文献信息

• [EN] GLUCOCORTICOID RECEPTOR LIGANDS FOR THE TREATMENT OF METABOLIC DISORDERS<br/>[FR] LIGANDS DE RECEPTEURS GLUCOCORTICOIDES POUR LE TRAITEMENT DE TROUBLES METABOLIQUES
  申请人：ABBOTT LAB

  公开号：WO2004000869A1

  公开（公告）日：2003-12-31

  This invention relates to novel compounds that are liver selective glucocorticoid receptor antagonists, to methods of preparing such compounds, and to methods for using such compounds in the regulation of metabolism, especially lowering serum glucose levels, insulin levels, or lipid levels, and/or decreasing body weight.

  这项发明涉及一种新型化合物，它们是肝选择性糖皮质激素受体拮抗剂，涉及制备这种化合物的方法，以及利用这种化合物在调节新陈代谢方面的方法，特别是降低血清葡萄糖水平、胰岛素水平或脂质水平，和/或减少体重。
• Novel glucocorticoid receptor ligands for the treatment of metabolic disorders
  申请人：——

  公开号：US20040235810A1

  公开（公告）日：2004-11-25

  This invention relates to novel compounds that are liver selective glucocorticoid receptor antagonists, to methods of preparing such compounds, and to methods for using such compounds in the regulation of metabolism, especially lowering serum glucose levels, insulin levels, or lipid levels, and/or decreasing body weight.

  本发明涉及一种肝脏选择性糖皮质激素受体拮抗剂的新化合物，涉及制备这种化合物的方法，以及利用这种化合物在调节新陈代谢方面的方法，特别是降低血清葡萄糖水平、胰岛素水平或脂质水平，和/或减轻体重。
• Glucocorticoid receptor ligands for the treatment of metabolic disorders
  申请人：Karo Bio AB

  公开号：US07141559B2

  公开（公告）日：2006-11-28

  This invention relates to novel compounds that are liver selective glucocorticoid receptor antagonists, to methods of preparing such compounds, and to methods for using such compounds in the regulation of metabolism, especially lowering serum glucose levels, insulin levels, or lipid levels, and/or decreasing body weight.

  本发明涉及一种新型化合物，其为肝脏选择性糖皮质激素受体拮抗剂，涉及制备这种化合物的方法，以及使用这种化合物调节新陈代谢的方法，特别是降低血清葡萄糖水平、胰岛素水平或脂质水平，和/或减轻体重。
• Substituted 2,3-Dihydrobenzofuranyl Compounds And Uses Thereof
  申请人：KARYOPHARM THERAPEUTICS INC.

  公开号：US20160221994A1

  公开（公告）日：2016-08-04

  The invention generally relates to substituted 2,3-dihydrobenzofuranyl compounds, and more particularly to a compound represented by Structural Formula (I), or a pharmaceutically acceptable salt thereof, wherein the variables are as defined and described herein. The invention also includes the synthesis and use of a compound of Structural Formula (I), or a pharmaceutically acceptable salt or composition thereof, e.g., in the treatment of cancer (e.g., mantle cell lymphoma), and other diseases and disorders.

  本发明通常涉及取代的2,3-二氢苯并呋喃基化合物，更具体地涉及由结构式（I）表示的化合物，或其药学上可接受的盐，在此变量的定义和描述中。本发明还包括合成和使用结构式（I）的化合物，或其药学上可接受的盐或组合物，例如在治疗癌症（例如曼托细胞淋巴瘤）和其他疾病和障碍中。
• Thermotropic and Lyotropic Liquid Crystalline Phases of Rigid Aromatic Amphiphiles
  作者：Marius Kölbel、Tom Beyersdorff、Carsten Tschierske、Siegmar Diele、Jens Kain

  DOI：10.1002/1521-3765(20001016)6:20<3821::aid-chem3821>3.0.co;2-8

  日期：2000.10.16

  Rodlike amphiphilic molecules that contain exclusively aromatic building-blocks and no flexible alkyl chains have been synthesized and their mesomorphic properties investigated. These novel compounds bear diol head groups of different size (2,3-dihydroxypropyloxy or 5,6-dihydroxy-3-oxahexyloxy groups) at one end of a biphenyl unit, various aromatic segments (banzyloxy, 4-, 3-, or 2-methylbenzyloxy, phenoxy groups) at the other, and additional methyl substituents in different positions. They were synthesized by using Suzuki cross-coupling reactions as the key steps. Their thermotropic mesomorphism was investigated by means of polarized light optical microscopy, differential scanning calorimetry, and, for enantiotropic phases, by X-ray scattering. The liquid crystallinity of this class of compounds is influenced by protic solvents, such as water and glycerol. Dependent on the temperature and the solvent content, different S-A phases were found. Several mesophases resulting from the frustration of these layer structures (e.g., different columnar phases, optical isotropic mesophases, and nematic phases) were also present. The smectic phases have different degrees of intercalation (S-Ad, S-A2) The columnar phases are supposed to be ribbon structures that result from the collapse of the smectic layers. They occur in some pure compounds or they are induced upon the addition of protic solvents. The particular phase sequences of the different compounds depend mainly on the position of the methyl substituents at the biphenyl cores and are largely determined by the degree of intercalation of the aromatic cores.